Shunmuga Sundaram Ponnusamy,Pugazhendhi Vijayaraman
Shunmuga Sundaram Ponnusamy
Cardiac pacing is the treatment of choice for the management of patients with bradycardia. Although right ventricular apical pacing is the standard therapy, it is associated with an increased risk of pacing-induced cardiomyopathy and heart ...
Evaluation and Management of Heart Block After Transcatheter Aortic Valve Replacement [0.03%]
经导管主动脉瓣置换术后心脏传导阻滞的评估与管理
Anthony J Mazzella,Sameer Arora,Michael J Hendrickson et al.
Anthony J Mazzella et al.
Transcatheter aortic valve replacement (TAVR) has developed substantially since its inception. Improvements in valve design, valve deployment technologies, preprocedural imaging and increased operator experience have led to a gradual declin...
José Silva-Cardoso,José Ramón González Juanatey,Josep Comin-Colet et al.
José Silva-Cardoso et al.
Telemedicine (TM) is potentially a way of escalating heart failure (HF) multidisciplinary integrated care. Despite the initial efforts to implement TM in HF management, we are still at an early stage of its implementation. The coronavirus d...
Umar Ismail,Kiran Sidhu,Shelley Zieroth
Umar Ismail
Hyperkalaemia has become an increasingly prevalent finding in patients with heart failure (HF), especially with renin-angiotensin-aldosterone system (RAAS) inhibitors and angiotensin-neprilysin inhibitors being the cornerstone of medical th...
Fatal Enterovirus-related Myocarditis in a Patient with Devic's Syndrome Treated with Rituximab [0.03%]
一名接受利妥昔单抗治疗的Devic氏综合征患者发生致命肠道病毒性心肌炎
Ava Diarra,Guillaume Gantois,Mouna Lazrek et al.
Ava Diarra et al.
Enteroviruses are a frequent source of infection and among the most common central nervous system viral pathogens. Enteroviruses - in particular, the Coxsackie B viruses - are a known cause of myocarditis. Rituximab is a genetically enginee...
Arvind Singhal,Martin R Cowie
Arvind Singhal
Digital health encompasses the use of information and communications technology and the use of advanced computing sciences in healthcare. This review covers the application of digital health in heart failure patients, focusing on teleconsul...
CardioMEMS Implantation Using Gadolinium-based Contrast Agent: A Case Report [0.03%]
使用钆基对比剂进行 CardioMEMS 植入的病例报告
Aniket S Rali,Lynne W Stevenson,Sandip K Zalawadiya
Aniket S Rali
A 57-year-old woman with New York Heart Association Class III heart failure requiring multiple hospitalisations over the previous year presented for CardioMEMS implantation. Because of the patient's allergy history of anaphylaxis to iodine-...
Rationale for and Practical Use of Sacubitril/Valsartan in the Patient's Journey with Heart Failure and Reduced Ejection Fraction [0.03%]
心力衰竭射血分数降低患者的治疗历程中使用尼麦心安的研究依据和实用方法
Mauro Gori,James L Januzzi,Emilia D&#x;Elia et al.
Mauro Gori et al.
Sacubitril with valsartan (sacubitril/valsartan) is a relatively novel compound that has become a milestone in the treatment of patients with chronic heart failure (HF) with reduced ejection fraction (HFrEF) in the last decade. Contemporary...
Ersilia M DeFilippis,Yasbanoo Moayedi,Nosheen Reza
Ersilia M DeFilippis
Women have been integral in the development of advanced heart failure (HF) and transplantation as a clinical subspecialty of cardiovascular medicine. However, women remain underrepresented in leadership positions, senior academic ranks and ...
Chris Wai Hang Lo,Yue Fei,Bernard Man Yung Cheung
Chris Wai Hang Lo
Type 2 diabetes is among the most prevalent chronic diseases worldwide and the prevention of associated cardiovascular complications is an important treatment goal. Sodium-glucose co-transporter 2 (SGLT2) inhibitors, glucagon-like peptide 1...